PRO1107 in Patients With Advanced Solid Tumors
Genmab
Genmab
Seagen Inc.
Fusion Pharmaceuticals Inc.
Tempus AI
NiKang Therapeutics, Inc.
Bolt Biotherapeutics, Inc.
Numab Therapeutics AG
NuCana plc
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc.
Pfizer
Aminex Therapeutics, Inc.
Five Prime Therapeutics, Inc.
Haihe Biopharma Co., Ltd.
pharmaand GmbH
Fate Therapeutics
Zai Lab (Hong Kong), Ltd.
Novartis
Incyte Corporation
CureOne
Otsuka Novel Products GmbH
Calando Pharmaceuticals